A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: penetration (10), access (1000)

HSCTRituximab_100mg-7day

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT RITUXIMAB 100mg (Weekly) Regimen • HSCT Allograft - Rituximab (7 day-100mg) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTRituximab-100mg-7day.pdf

Epirubicin (7) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER EPIRUBICIN (7 day) Regimen Breast Cancer – Epirubicin (7 day) Indication Treatment of locally adv
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastEpirubicin7Ver11.pdf

Doxorubicin (7) Ver1.1

Description
Chemotherapy Protocol BREAST CANCER DOXORUBICIN (7 day) Regimen Breast Cancer – Doxorubicin (7 day) Indication Treatment of locally ad
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/BreastDoxorubicin7Ver11.pdf

Cabozantinib

Description
Chemotherapy Protocol RENAL CELL CANCER Regimen CABOZANTINIB • Renal Cell – Cabozantinib (60mg-tablets) Indication • Cabozantinib s ind
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Cabozantinib.pdf

Rituximab SC (8 weekly) Ver 1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance single agent the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance single agent t
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Rituximab (8 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (8 Weekly) Regimen Lymphoma – Rituximab (8 weekly) Indication Non-Hodgkin’s Lymphoma as first-li
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-8-weekly.pdf

Rituximab (12 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (12 weekly) Regimen Lymphoma – Rituximab (12 Weekly) Indication Non- Hodgkin’s Lymphoma as maint
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-12-weekly.pdf

Lenalidomide Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE There are multiple versions of this protocol in use. Please ensure you have the correct pro
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-Ver-1.1.pdf

Gemcitabine-Vinorelbine Ver1.1

Description
Chemotherapy Protocol LYMPHOMA GEMCITABINE-VINORELBINE Regimen Lymphoma – Gemcitabine-Vinorelbine Indication Relapsed or refractory Non
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Gemcitabine-Vinorelbine-Ver1.1.pdf
51 to 60 of 167
Previous … 4 5 6 7 8 … Next